ARCHIVES

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Georgetown Sponsors Oncology Agent Development Meeting

February 21, 2003

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

Senate Commitee Approves $1.058 Trillion To Reverse Sequestration Cuts

June 21, 2013

ASCO Growth Changes, Prepare Society for ‘90s

June 8, 1990

Cullen To Leave NCI, Will Become Director Of AMC Cancer Center; Nixon May Join ACS

April 14, 1989

Komen Deal With KFC Yields Buckets Of Discord

April 23, 2010